NCT02466399View on ClinicalTrials.gov

POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Glaucoma
Interventions
DRUG

POLAT-001

Subconjunctival injection

DRUG

Latanoprost ophthalmic solution

Latanoprost ophthalmic solution q.d., evening

Trial Locations (1)

29445

Professional Research Network, Goose Creek

Sponsors
All Listed Sponsors
lead

Peregrine Ophthalmic

INDUSTRY

NCT02466399 - POLAT-001 Compared to Latanoprost Ophthalmic Solution in Patients With Ocular Hypertension and Open-angle Glaucoma | Biotech Hunter | Biotech Hunter